287 related articles for article (PubMed ID: 10406819)
1. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.
Yang XP; Liu YH; Shesely EG; Bulagannawar M; Liu F; Carretero OA
Hypertension; 1999 Jul; 34(1):24-30. PubMed ID: 10406819
[TBL] [Abstract][Full Text] [Related]
2. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
[TBL] [Abstract][Full Text] [Related]
3. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury.
Jones SP; Greer JJ; Kakkar AK; Ware PD; Turnage RH; Hicks M; van Haperen R; de Crom R; Kawashima S; Yokoyama M; Lefer DJ
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H276-82. PubMed ID: 12969888
[TBL] [Abstract][Full Text] [Related]
4. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
[TBL] [Abstract][Full Text] [Related]
5. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model.
Hannan RL; John MC; Kouretas PC; Hack BD; Matherne GP; Laubach VE
J Surg Res; 2000 Sep; 93(1):127-32. PubMed ID: 10945953
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren protects against myocardial ischaemia-reperfusion injury via an endothelial nitric oxide synthase dependent manner.
Chen Y; Meng G; Bai W; Ma Y; Xie L; Altaf N; Qian Y; Han Y; Ji Y
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):266-274. PubMed ID: 27809355
[TBL] [Abstract][Full Text] [Related]
7. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats.
Fu Y; Wang Z; Chen WL; Moore PK; Zhu YZ
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1545-52. PubMed ID: 17526656
[TBL] [Abstract][Full Text] [Related]
9. Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice.
Flögel U; Decking UK; Gödecke A; Schrader J
J Mol Cell Cardiol; 1999 Apr; 31(4):827-36. PubMed ID: 10329210
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
11. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase.
Jones SP; Girod WG; Palazzo AJ; Granger DN; Grisham MB; Jourd'Heuil D; Huang PL; Lefer DJ
Am J Physiol; 1999 May; 276(5):H1567-73. PubMed ID: 10330240
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
[TBL] [Abstract][Full Text] [Related]
13. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.
Kuhlencordt PJ; Gyurko R; Han F; Scherrer-Crosbie M; Aretz TH; Hajjar R; Picard MH; Huang PL
Circulation; 2001 Jul; 104(4):448-54. PubMed ID: 11468208
[TBL] [Abstract][Full Text] [Related]
14. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
15. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice.
Massion PB; Balligand JL
J Physiol; 2003 Jan; 546(Pt 1):63-75. PubMed ID: 12509479
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.
Bell RM; Yellon DM
J Mol Cell Cardiol; 2003 Feb; 35(2):185-93. PubMed ID: 12606259
[TBL] [Abstract][Full Text] [Related]
18. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
Brunner F; Maier R; Andrew P; Wölkart G; Zechner R; Mayer B
Cardiovasc Res; 2003 Jan; 57(1):55-62. PubMed ID: 12504814
[TBL] [Abstract][Full Text] [Related]
20. Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril.
Cargnoni A; Comini L; Bernocchi P; Bachetti T; Ceconi C; Curello S; Ferrari R
Br J Pharmacol; 2001 May; 133(1):145-53. PubMed ID: 11325804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
